scholarly journals Anomalous Origin of Left Pulmonary Artery From the Aorta: A Rare Entity in Congenital Heart Disease

2019 ◽  
Vol 107 (3) ◽  
pp. e181-e182 ◽  
Author(s):  
Melanie R.F. Gropler ◽  
Aarti S. Dalal ◽  
Andrew J. Bierhals ◽  
Erin Romberg ◽  
Gautam K. Singh ◽  
...  
2021 ◽  
Vol 10 (01) ◽  
pp. e9-e10
Author(s):  
Keisuke Shibagaki ◽  
Chikara Shiiku ◽  
Hiroyuki Kamiya ◽  
Yoichi Kikuchi

AbstractAn anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) is a rare congenital heart disease. Among the variants, an anomalous origin of the left anterior descending coronary artery from the pulmonary artery (ALADPA) is extremely rare. Here, we report a case of ALADPA in an adult that was treated with coronary artery bypass grafting using the left internal thoracic artery.


2013 ◽  
Vol 24 (5) ◽  
pp. 926-928 ◽  
Author(s):  
Arima Nigam ◽  
Vijay Trehan

AbstractHemitruncus is a rare congenital heart disease. Anomalous origin of the left pulmonary artery is not only rare but also pathogenetically different from anomalous origin of the right pulmonary artery from the ascending aorta. In most cases in isolated hemitrucus pressures in the right ventricle and the normally originating pulmonary artery are systemic or suprasystemic. We present a rare case of anomalous origin of the left pulmonary artery from the ascending aorta diagnosed in an adult with normal pressures in the right ventricle and normally originating pulmonary artery. To the best of our knowledge, this unique haemodynamics has never been reported in the literature.


2015 ◽  
Vol 02 (01) ◽  
pp. 31-33
Author(s):  
Charul Purani ◽  
K M Mehariya ◽  
Kirti Gupta ◽  
Priyansi Patel

2020 ◽  
Vol 10 (2) ◽  
pp. 204589402092211
Author(s):  
Terry Zhu ◽  
Samuel Chiacchia ◽  
Rebecca J. Kameny ◽  
Antoni Garcia De Herreros ◽  
Wenhui Gong ◽  
...  

The risk and progression of pulmonary vascular disease in patients with congenital heart disease is dependent on the hemodynamics associated with different lesions. However, the underlying mechanisms are not understood. Endothelin-1 is a potent vasoconstrictor that plays a key role in the pathology of pulmonary vascular disease. We utilized two ovine models of congenital heart disease: (1) fetal aortopulmonary graft placement (shunt), resulting in increased flow and pressure; and (2) fetal ligation of the left pulmonary artery resulting in increased flow and normal pressure to the right lung, to investigate the hypothesis that high pressure and flow, but not flow alone, upregulates endothelin-1 signaling. Lung tissue and pulmonary arterial endothelial cells were harvested from control, shunt, and the right lung of left pulmonary artery lambs at 3–7 weeks of age. We found that lung preproendothelin-1 mRNA and protein expression were increased in shunt lambs compared to controls. Preproendothelin-1 mRNA expression was modestly increased, and protein was unchanged in left pulmonary artery lambs. These changes resulted in increased lung endothelin-1 levels in shunt lambs, while left pulmonary artery levels were similar to controls. Pulmonary arterial endothelial cells exposed to increased shear stress decreased endothelin-1 levels by five-fold, while cyclic stretch increased levels by 1.5-fold. These data suggest that pressure or an additive effect of pressure and flow, rather than increased flow alone, is the principal driver of increased endothelin signaling in congenital heart disease. Defining the molecular drivers of the pathobiology of pulmonary vascular disease due to differing mechanical forces will allow for a more targeted therapeutic approach.


2008 ◽  
Vol 17 (3) ◽  
pp. 190-191 ◽  
Author(s):  
Emanuela Angeli ◽  
Carlo Pace Napoleone ◽  
Guido Oppido ◽  
Sofia Martìn-Suàrez ◽  
Gaetano Gargiulo

Sign in / Sign up

Export Citation Format

Share Document